- Home
- MDGL vs ELS Comparison
MDGL vs ELS Comparison
Compare MDGL & ELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | ELS |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 11.7B |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | MDGL | ELS |
|---|---|---|
| Price | $482.19 | $64.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $597.54 | $70.50 |
| AVG Volume (30 Days) | 312.8K | ★ 1.5M |
| Earning Date | 02-25-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 3.22% |
| EPS Growth | N/A | ★ 2.36 |
| EPS | N/A | ★ 1.99 |
| Revenue | $740,640,000.00 | ★ $1,535,911,000.00 |
| Revenue This Year | $435.62 | $1.08 |
| Revenue Next Year | $52.67 | $4.39 |
| P/E Ratio | ★ N/A | $32.10 |
| Revenue Growth | ★ 864.21 | 0.93 |
| 52 Week Low | $265.00 | $58.15 |
| 52 Week High | $615.00 | $70.35 |
Technical Indicators
Market Signals| Indicator | MDGL | ELS |
|---|---|---|
| Relative Strength Index (RSI) | 31.14 | 65.36 |
| Support Level | $483.55 | $61.69 |
| Resistance Level | $511.94 | $63.73 |
| Average True Range (ATR) | 23.79 | 1.14 |
| MACD | -6.68 | 0.37 |
| Stochastic Oscillator | 12.67 | 96.32 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the US with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.